Search Results

There are 24382 results for: content related to: Further data supporting that paclitaxel-associated acute pain syndrome is associated with development of peripheral neuropathy

  1. North Central Cancer Treatment Group/Alliance trial N08CA—the use of glutathione for prevention of paclitaxel/carboplatin-induced peripheral neuropathy: A phase 3 randomized, double-blind, placebo-controlled study

    Cancer

    Volume 120, Issue 12, 15 June 2014, Pages: 1890–1897, Alexis D. Leal, Rui Qin, Pamela J. Atherton, Paul Haluska, Robert J. Behrens, Charles H. Tiber, Patanit Watanaboonyakhet, Matthias Weiss, Paul T. Adams, Travis J. Dockter, Charles L. Loprinzi and for the Alliance for Clinical Trials in Oncology

    Article first published online : 11 MAR 2014, DOI: 10.1002/cncr.28654

  2. You have free access to this content
    Chemotherapy-induced peripheral neurotoxicity: A critical analysis

    CA: A Cancer Journal for Clinicians

    Volume 63, Issue 6, November/December 2013, Pages: 419–437, Susanna B. Park, David Goldstein, Arun V. Krishnan, Cindy S-Y Lin, Michael L. Friedlander, James Cassidy, Martin Koltzenburg and Matthew C. Kiernan

    Article first published online : 11 NOV 2013, DOI: 10.3322/caac.21204

  3. You have full text access to this OnlineOpen article
    Comparison of doxorubicin and weekly paclitaxel efficacy in metastatic angiosarcomas

    Cancer

    Volume 118, Issue 13, 1 July 2012, Pages: 3330–3336, Antoine Italiano, Angela Cioffi, Nicolas Penel, Matteo Giaj Levra, Corinne Delcambre, Elsa Kalbacher, Christine Chevreau, François Bertucci, Nicolas Isambert, Jean-Yves Blay, Binh Bui, Cristina Antonescu, David R. D'Adamo, Robert G. Maki and Mary Louise Keohan

    Article first published online : 1 NOV 2011, DOI: 10.1002/cncr.26599

  4. Chemotherapy-induced peripheral neurotoxicity can be misdiagnosed by the National Cancer Institute Common Toxicity scale

    Journal of the Peripheral Nervous System

    Volume 16, Issue 3, September 2011, Pages: 228–236, Barbara Frigeni, Marialuisa Piatti, Francesca Lanzani, Paola Alberti, Patrizia Villa, Claudio Zanna, Maurizio Ceracchi, Massimo Ildebrando and Guido Cavaletti

    Article first published online : 17 OCT 2011, DOI: 10.1111/j.1529-8027.2011.00351.x

  5. You have full text access to this OnlineOpen article
    A randomized phase 2 study of temozolomide and bevacizumab or nab-paclitaxel, carboplatin, and bevacizumab in patients with unresectable stage IV melanoma

    Cancer

    Volume 119, Issue 3, 1 February 2013, Pages: 586–592, Lisa A. Kottschade, Vera J. Suman, Domingo G. Perez, Robert R. McWilliams, Judith S. Kaur, Thomas T. Amatruda III, Francois J. Geoffroy, Howard M. Gross, Peter A. Cohen, Anthony J. Jaslowski, Matthew L. Kosel and Svetomir N. Markovic

    Article first published online : 22 AUG 2012, DOI: 10.1002/cncr.27760

  6. You have free access to this content
    A prospective surveillance model for physical rehabilitation of women with breast cancer

    Cancer

    Volume 118, Issue S8, 15 April 2012, Pages: 2250–2260, Michael D. Stubblefield, Margaret L. McNeely, Catherine M. Alfano and Deborah K. Mayer

    Article first published online : 6 APR 2012, DOI: 10.1002/cncr.27463

  7. Measures of chemotherapy-induced peripheral neuropathy: a systematic review of psychometric properties

    Journal of the Peripheral Nervous System

    Volume 15, Issue 4, December 2010, Pages: 314–325, Kathleen A. Griffith, Ingemar S. J. Merkies, Elizabeth E. Hill and David R. Cornblath

    Article first published online : 29 DEC 2010, DOI: 10.1111/j.1529-8027.2010.00292.x

  8. The Total Neuropathy Score as an assessment tool for grading the course of chemotherapy-induced peripheral neurotoxicity: comparison with the National Cancer Institute-Common Toxicity Scale

    Journal of the Peripheral Nervous System

    Volume 12, Issue 3, September 2007, Pages: 210–215, Guido Cavaletti, 1 Barbara Frigeni, 1 Francesca Lanzani, 1 Marialuisa Piatti, 2 Stefania Rota, 1 Chiara Briani, 3 Gabriella Zara, 3 Rosaria Plasmati, 4 Francesca Pastorelli, 4 Augusto Caraceni, 5 Andrea Pace, 6 Mariagrazia Manicone, 7 Andrea Lissoni, 8 Nicoletta Colombo, 8,9 Giulia Bianchi, 10 Claudio Zanna and 11 Italian NETox Group

    Article first published online : 14 SEP 2007, DOI: 10.1111/j.1529-8027.2007.00141.x

  9. PARP inhibitors attenuate chemotherapy-induced painful neuropathy

    Journal of the Peripheral Nervous System

    Volume 17, Issue 3, September 2012, Pages: 324–330, Jill-Desiree Brederson, Shailen K. Joshi, Kaitlin E. Browman, Joseph Mikusa, Chengmin Zhong, Donna Gauvin, Xuesong Liu, Yan Shi, Thomas D. Penning, Alex R. Shoemaker and Vincent L. Giranda

    Article first published online : 13 SEP 2012, DOI: 10.1111/j.1529-8027.2012.00413.x

  10. Long-term cardiac safety and outcomes of dose-dense doxorubicin and cyclophosphamide followed by paclitaxel and trastuzumab with and without lapatinib in patients with early breast cancer

    Cancer

    Volume 119, Issue 22, 15 November 2013, Pages: 3943–3951, Patrick G. Morris, Neil M. Iyengar, Sujata Patil, Carol Chen, Alyson Abbruzzi, Robert Lehman, Richard Steingart, Kevin C. Oeffinger, Nancy Lin, Beverley Moy, Steven E. Come, Eric P. Winer, Larry Norton, Clifford A. Hudis and Chau T. Dang

    Article first published online : 26 AUG 2013, DOI: 10.1002/cncr.28284

  11. You have full text access to this OnlineOpen article
    Comparative effectiveness of three platinum-doublet chemotherapy regimens in elderly patients with advanced non–small cell lung cancer

    Cancer

    Volume 119, Issue 11, 1 June 2013, Pages: 2048–2060, Junya Zhu, Dhruv B. Sharma, Aileen B. Chen, Bruce E. Johnson, Jane C. Weeks and Deborah Schrag

    Article first published online : 5 APR 2013, DOI: 10.1002/cncr.28022

  12. You have full text access to this OnlineOpen article
    A phase 2 trial of induction nab-paclitaxel and cetuximab given with cisplatin and 5-fluorouracil followed by concurrent cisplatin and radiation for locally advanced squamous cell carcinoma of the head and neck

    Cancer

    Volume 119, Issue 4, 15 February 2013, Pages: 766–773, Douglas Adkins, Jessica Ley, Kathryn Trinkaus, Wade Thorstad, James Lewis Jr, Tanya Wildes, Barry A. Siegel, Farrokh Dehdashti, Hiram Gay, Paul Mehan and Brian Nussenbaum

    Article first published online : 18 SEP 2012, DOI: 10.1002/cncr.27741

  13. You have full text access to this OnlineOpen article
    Therapy of chemotherapy-induced peripheral neuropathy

    British Journal of Haematology

    Volume 145, Issue 1, April 2009, Pages: 3–14, Thomas J. Kaley and Lisa M. DeAngelis

    Article first published online : 20 JAN 2009, DOI: 10.1111/j.1365-2141.2008.07558.x

  14. Tubulin-β-III overexpression by uterine serous carcinomas is a marker for poor overall survival after platinum/taxane chemotherapy and sensitivity to epothilones

    Cancer

    Volume 119, Issue 14, 15 July 2013, Pages: 2582–2592, Dana M. Roque, Stefania Bellone, Diana P. English, Natalia Buza, Emiliano Cocco, Sara Gasparrini, Ileana Bortolomai, Elena Ratner, Dan-Arin Silasi, Masoud Azodi, Thomas J. Rutherford, Peter E. Schwartz and Alessandro D. Santin

    Article first published online : 12 APR 2013, DOI: 10.1002/cncr.28017

  15. A randomized, open-label clinical trial of tasisulam sodium versus paclitaxel as second-line treatment in patients with metastatic melanoma

    Cancer

    Volume 120, Issue 13, 1 July 2014, Pages: 2016–2024, Omid Hamid, Robert Ilaria Jr, Claus Garbe, Pascal Wolter, Michele Maio, Thomas E. Hutson, Ana Arance, Paul Lorigan, Jeeyun Lee, Axel Hauschild, Peter Mohr, Marjo Hahka-Kemppinen, Christopher Kaiser, P. Kellie Turner, Ilaria Conti and Jean-Jacques Grob

    Article first published online : 26 MAR 2014, DOI: 10.1002/cncr.28635

  16. Cannabidiol inhibits paclitaxel-induced neuropathic pain through 5-HT1A receptors without diminishing nervous system function or chemotherapy efficacy

    British Journal of Pharmacology

    Volume 171, Issue 3, February 2014, Pages: 636–645, Sara Jane Ward, Sean D McAllister, Rumi Kawamura, Ryuchi Murase, Harshini Neelakantan and Ellen A Walker

    Article first published online : 13 JAN 2014, DOI: 10.1111/bph.12439

  17. You have full text access to this OnlineOpen article
    Current and emerging targeted therapies for metastatic breast cancer

    Cancer

    Volume 118, Issue 12, 15 June 2012, Pages: 3014–3025, Edith A. Perez and Jean-Philippe Spano

    Article first published online : 17 OCT 2011, DOI: 10.1002/cncr.26356

  18. You have full text access to this OnlineOpen article
    Human immunodeficiency virus-associated lung cancer in the era of highly active antiretroviral therapy

    Cancer

    Volume 118, Issue 1, 1 January 2012, Pages: 164–172, Suchita Pakkala, Zhengjia Chen, David Rimland, Taofeek K. Owonikoko, Clifford Gunthel, Johann R. Brandes, Nabil R. Saba, Dong M. Shin, Walter J. Curran Jr., Fadlo R. Khuri and Suresh S. Ramalingam

    Article first published online : 28 JUN 2011, DOI: 10.1002/cncr.26242

  19. You have free access to this content
    Chemotherapy-Induced Polyneuropathy: Major Agents and Assessment by Questionnaires

    Basic & Clinical Pharmacology & Toxicology

    Ahmed H. Zedan and Ole J. Vilholm

    Article first published online : 24 MAY 2014, DOI: 10.1111/bcpt.12262

  20. Chemotherapy-induced peripheral neurotoxicity (CIPN): what we need and what we know

    Journal of the Peripheral Nervous System

    Accepted manuscript online: 26 JUN 2014, Guido Cavaletti

    DOI: 10.1111/jns5.12073